
Presenting on Tuesday February 11th, at 11:15 AM in the Royale Room.
Ziphius, a Belgium/US-based private biotech company, is advancing a next-generation platform utilizing self-amplifying RNA (saRNA) and lipid nanoparticles (LNPs) to develop first and best in class medicines for infectious diseases, rare diseases, and oncology.
Address
New YorkNew York
United States